Characteristics of Marijuana Use During Pregnancy — Eight States, Pregnancy Risk Assessment Monitoring System, 2017
Jean Y. Ko(National Center for Chronic Disease Prevention and Health Promotion), Althea M. Grant(Centers for Disease Control and Prevention), Kelsey C. Coy, Sarah C. Haight, Shanna Cox(National Center for Chronic Disease Prevention and Health Promotion), L. Williams, Rashid Njai(Department of Human Services), Tamara M. Haegerich(National Institute on Drug Abuse)
Cited by 133
Related Papers
Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|2.8k
Racial/Ethnic Disparities in Pregnancy-Related Deaths — United States, 2007–2016
|MMWR Morbidity and Mortality Weekly Report|2019|867
<i>Vital Signs:</i> Pregnancy-Related Deaths, United States, 2011–2015, and Strategies for Prevention, 13 States, 2013–2017
|MMWR Morbidity and Mortality Weekly Report|2019|804
National Estimates of Marijuana Use and Related Indicators — National Survey on Drug Use and Health, United States, 2002–2014
|MMWR Surveillance Summaries|2016|465
Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization — United States, 2017–2019
|MMWR Morbidity and Mortality Weekly Report|2022|442